This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
A yearly strategy formalizes harvest windows, helping you optimize tax outcomes while staying invested in index funds.
22,166 articlesA biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
In a year of AI-driven demand, SOXX outpaced XSD thanks to a cap-weighted tilt toward megacaps. The gap highlights ho...
Venture funding in the U.S. hit a record in the first half of 2026, led by AI mega-deals, while exits skew toward Spa...
A fresh $75 million fund backs consumer brands with cultural punch. The 29-year investor went from early, risky bets ...
Investors are watching the Fed closely as warnings mount. This guide explains why the federal reserve raising flags m...
A surprising rally in small-cap value equities challenges the usual price-pressures from inflation and higher rates. ...
The SEC has launched a public-comment process on novel ETFs, signaling tighter rules for crypto assets and leverage a...
Investors looking at cannabis real estate need to understand how Innovative Industrial Properties reports earnings. T...
Oil prices surged this week as markets faced renewed supply worries. The piece outlines practical ways americans can ...
A 1,096 BTC allocation linked to Cardano’s 2016 audit is now worth about $70 million, triggering a governance dispute...
The idea that skilled trades could become high earners is reshaping how investors view AI-driven growth. This piece c...
When a space tech company makes a big fundraising move, its stock can swing just as fast. Learn why intuitive machine...